Hyphens Pharma International Limited (SGX:1J5)

SGXC:1J5 Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	185.32	195.42	170.6	162.32	125.88	120.98
Revenue Growth (YoY)	-5.22%	14.55%	5.10%	28.94%	4.06%	1.29%
Cost of Revenue	118.68	127.18	109.57	100.04	78.47	79.39
Gross Profit	66.64	68.24	61.03	62.28	47.41	41.58
Selling, General & Admin	56.6	54.91	50.02	47.83	39.62	36.66
Operating Expenses	56.6	54.91	50.02	47.83	39.62	36.66
Operating Income	10.05	13.34	11.01	14.45	7.79	4.92
Interest Expense	-0.67	-0.57	-0.28	-0.24	-0.1	-0.11
Interest & Investment Income	0.15	0.15	0.34	0.04	0.07	0.18
Earnings From Equity Investments	-	-	0.55	0.47	0.02	-
Currency Exchange Gain (Loss)	-1.53	-0.35	-1.41	-0.92	0.46	0.05
Other Non Operating Income (Expenses)	0.44	0.44	0.19	0.49	0.43	0.3
EBT Excluding Unusual Items	8.45	13.02	10.4	14.29	8.68	5.34
Merger & Restructuring Charges	-0.07	-0.07	-	-	-0.42	-
Gain (Loss) on Sale of Investments	-	-	0.17	-	-	-
Gain (Loss) on Sale of Assets	0.01	0.01	0.01	-0	-0	0
Other Unusual Items	-	-	-	-	-	1.77
Pretax Income	8.39	12.96	10.57	14.29	8.26	7.11
Income Tax Expense	1.43	2.1	1.99	2.88	1.41	0.95
Earnings From Continuing Operations	6.96	10.86	8.58	11.41	6.85	6.16
Minority Interest in Earnings	-0.5	-0.66	-0.01	-0.06	-	-
Net Income	6.46	10.19	8.57	11.35	6.85	6.16
Net Income to Common	6.46	10.19	8.57	11.35	6.85	6.16
Net Income Growth	-37.98%	18.98%	-24.52%	65.81%	11.08%	-5.62%
Shares Outstanding (Basic)	310	309	309	309	301	300
Shares Outstanding (Diluted)	316	315	309	310	302	300
Shares Change (YoY)	1.38%	1.74%	-0.27%	2.66%	0.60%	0.05%
EPS (Basic)	0.02	0.03	0.03	0.04	0.02	0.02
EPS (Diluted)	0.02	0.03	0.03	0.04	0.02	0.02
EPS Growth	-38.79%	16.97%	-24.32%	61.23%	10.73%	-5.73%
Free Cash Flow	6.84	-1.12	5.34	16.32	5.34	3.76
Free Cash Flow Per Share	0.02	-0.00	0.02	0.05	0.02	0.01
Dividend Per Share	0.015	0.015	0.009	0.011	0.007	0.006
Dividend Growth	74.42%	74.42%	-22.52%	65.67%	8.06%	-38.00%
Gross Margin	35.96%	34.92%	35.77%	38.37%	37.66%	34.37%
Operating Margin	5.42%	6.83%	6.46%	8.90%	6.19%	4.07%
Profit Margin	3.49%	5.22%	5.02%	6.99%	5.44%	5.09%
Free Cash Flow Margin	3.69%	-0.57%	3.13%	10.05%	4.24%	3.11%
EBITDA	11.46	14.88	12.63	16.05	9.09	6.17
EBITDA Margin	6.19%	7.61%	7.40%	9.89%	7.22%	5.10%
D&A For EBITDA	1.42	1.54	1.62	1.6	1.3	1.25
EBIT	10.05	13.34	11.01	14.45	7.79	4.92
EBIT Margin	5.42%	6.83%	6.46%	8.90%	6.19%	4.07%
Effective Tax Rate	17.05%	16.24%	18.79%	20.17%	17.08%	13.30%
Advertising Expenses	-	9.26	8.87	8.24	8.58	8.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.